AgeX Therapeutics, Inc.
(NYSE Amex Equities : AGE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
1.20%142.130.7%$1093.48m
PFEPfizer Inc.
0.54%43.740.9%$891.19m
MRKMerck & Co., Inc.
-0.96%84.540.6%$747.01m
BMYBristol-Myers Squibb Company
0.70%48.951.4%$532.58m
LLYEli Lilly and Company
0.36%115.651.0%$485.48m
ABBVAbbVie, Inc.
1.55%78.812.2%$357.28m
NVSNovartis AG Sponsored ADR
0.57%92.430.2%$199.08m
AZNAstraZeneca PLC Sponsored ADR
0.31%41.811.2%$117.75m
GSKGlaxoSmithKline plc Sponsored ADR
-0.78%40.680.2%$89.28m
SNYSanofi Sponsored ADR
-0.13%44.030.2%$87.06m
NVONovo Nordisk A/S Sponsored ADR Class B
-2.39%51.170.1%$77.10m
LCILannett Company, Inc.
0.26%5.7036.6%$4.61m
AKTXAkari Therapeutics Plc Sponsored ADR
-5.02%2.081.6%$0.42m
EPIXESSA Pharma Inc
3.27%2.380.1%$0.01m

Company Profile

AgeX Therapeutics, Inc. operates as a biotechnology company. It focuses on the development and commercialization of novel therapeutics targeting human aging. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.